Please login to the form below

Not currently logged in
Email:
Password:

Digital intelligence blog

Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools

Otsuka joins its Japanese peers on Twitter

The firm's US operations make their social media debut

Otsuka's US operations have joined Twitter, catching up with many of their Japanese peers.

Taking a practical approach to potential pitfalls with the medium the firm has compiled a straightforward set of Twitter guidelines and used as its pinned tweet details of how to report side effects.

Many of Otsuka's fellow Japanese pharma companies have been using Twitter for some time, with Daiichi Sankyo making the most extensive use with seven accounts, including ones for Europe, Spain and Brazil.

Astellas also makes wide use of the social media platform, with accounts that include its US corporate operations, a publications-based account and one for the cycling team it sponsors.

Takeda, meanwhile, is rather more focused, opting for a corporate account and one for the corporate communications team of its US oncology operations.

Some of the main Japanese pharma companies on Twitter

@AstellasUS
@AstellasPubs
@astellascycling
@AstellasINNOV8
@AstellasFDN
@AstellasCZ

@EUdaiichisankyo
@DaiichiSankyoES
@DaiichiSankyoJP
@DaiichiSankyoBr
@DaiichiSankyo
@DaiichiSankyoUK [Tweets protected]

@OtsukaUS

@TakedaPharma
@TakedaOncology

25th May 2016

From: Marketing

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Hamell

Hamell is a full-service agency with a clear focus on delivering evidence-based, sustained behaviour change. So, whether you are looking...

Latest intelligence

Emre Vural
Sourcing R&D innovation: why pharma companies need to evolve their business models
Recent years have seen a significant shift in drug development to specialty areas...
2020 - a year to remember or forget?
2020 and the Covid pandemic brought immense challenges, and the need for change felt like it happened overnight. What have we learned and what does the future of agency working...
Gilead Headquarters
The search for effective drug treatments for COVID-19
PME talks to Julian Cole, Senior Director, Medical Affairs at Gilead Sciences...

Infographics